Fidelity Investments
JBIO

Fidelity Investments’s Jade Biosciences JBIO Stock Holding History

Fidelity Investments’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$203M Buy
9,126,877
+2,041,454
+29% +$42.6M 0.01% 921
2026
Q1 		$99.6M Buy
7,085,423
+190,935
+3% +$2.76M 0.01% 1182
2025
Q4 		$106M Buy
6,894,488
+2,005,707
+41% +$23.5M 0.01% 1151
2025
Q3 		$42.2M Buy
4,888,781
+53,398
+1% +$436K ﹤0.01% 1498
2025
Q2 		$48.3M Buy
4,835,383
+4,834,990
+1,230,277% +$165M ﹤0.01% 1414
2025
Q1 		$34.5K Sell
393
-5
-1% -$439 ﹤0.01% 4022
2024
Q4 		$36.9K Sell
398
-1,971
-83% -$170K ﹤0.01% 3987
2024
Q3 		$173K Buy
2,369
+2,365
+59,125% +$153K ﹤0.01% 3246
2024
Q2 		$254 Sell
4
-15,354
-100% -$10.2M ﹤0.01% 4910
2024
Q1 		$15.9M Buy
15,358
+1
+0% +$764 ﹤0.01% 1734
2023
Q4 		$12.2M Buy
15,357
+227
+2% +$116K ﹤0.01% 1787
2023
Q3 		$7.19M Sell
15,130
-5,659
-27% -$3.07M ﹤0.01% 1928
2023
Q2 		$12.5M Buy
20,789
+4,476
+27% +$2.86M ﹤0.01% 1790
2023
Q1 		$11.5M Buy
16,313
+3,251
+25% +$2.7M ﹤0.01% 1819
2022
Q4 		$13.4M Sell
13,062
-1,940
-13% -$1.41M ﹤0.01% 1777
2022
Q3 		$8.71M Sell
15,002
-3,134
-17% -$2.09M ﹤0.01% 1964
2022
Q2 		$9.92M Sell
18,136
-2,420
-12% -$1.16M ﹤0.01% 1971
2022
Q1 		$13.2M Buy
20,556
+32
+0.2% +$12.4K ﹤0.01% 2005
2021
Q4 		$8.47M Hold
20,524
– – ﹤0.01% 2178
2021
Q3 		$15.1M Sell
20,524
-5,071
-20% -$2.84M ﹤0.01% 1958
2021
Q2 		$22.2M Buy
+25,595
New +$20.5M ﹤0.01% 1809

Other funds holding JBIO

JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments's JBIO Position: Q2 2026 in Review

Fidelity Investments increased its Jade Biosciences (JBIO) stake by 29% in Q2 2026, buying an estimated $42.6M and bringing the position to 9,126,877 shares worth $203M. The position accounts for 0.01% of the portfolio, ranked #921.

Fidelity Investments first reported a position in JBIO in Q2 2021 and has held it in 21 quarters since. 154 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

  • Fidelity Investments held 9,126,877 shares of Jade Biosciences worth $203M as of Q2 2026.
  • Fidelity Investments bought 2,041,454 Jade Biosciences shares in Q2 2026, an estimated $42.6M.
  • Jade Biosciences made up 0.01% of Fidelity Investments's portfolio in Q2 2026, its #921 holding.
  • Fidelity Investments first reported a position in Jade Biosciences in Q2 2021 and has held it in 21 quarters since.
  • 154 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.